Study Title: Phase 3 Study of Epcoritamab, Rituximab, and Lenalidomide for First-Line Treatment of Follicular Lymphoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Brian Hess, at hessbr@musc.edu.Study Coordinator, Hana Baker, at bakerhan@musc.edu.Trial opened at the following institutions: Medical University of South Carolina